Navigation Links
Panacea Biotec In-Licenses FMD Vaccine

Panacea Biotec Ltd today said it has entered into an agreement with the National Research Development Corporation (NRDC) // for in-licensing of Foot and Mouth Disease (FMD) vaccine developed by the Indian Veterinary Research Institute.

'As part of the agreement, we will produce and market the vaccine in the Indian market first. As and when we meet the requirements of the domestic market and if there is extra capacity available we will also export it,' company's Joint Managing Director Rajesh Jain said.

He said the vaccine would be rolled out in the market in the next 18-24 months after completing the technology transfer and would take part in the government's tender process for supply of the vaccine for eradication of FMD in India.

'Initially, we are targeting a production of about 5 million doses which will be increased by 25-30 per cent annually,' he said.

Asked if production of the FMD vaccine would require any investment from the company, he replied in the negative and said, 'this will be manufactured at our multi-product facility.' Jain said the company expected a significant contribution from the FMD vaccine to its overall topline and bottomline growth, but 'it is too early to quantify at the moment.' 'When we are near to about six months of production we should be able to finalise the pricing of the vaccine,' he added.

NRDC Chairman and Managing Director Somentah Ghosh said the organisation had also signed a similar in-licensing agreement with another Indian company but declined to disclose citing a confidentiality clause.

(Source:PTI News)
'"/>




Page: 1

Related medicine news :

1. Panacea Biotech To Market Anthrax Vaccine
2. Panacea To Market Measles Vaccine In India
3. Websites That Offer Panacea for Eating Disorders may Be Dangerous
4. Biotechnology industry expected to grow into a three billion dollar industry by 2002
5. Biotechnology on the lead
6. Panacea Biotech To Market Anthrax Vaccine
7. Commercialization of Biotech Discoveries, An Encouragement For Researchers
8. Biotech drug causing anemia-EPREX
9. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
10. Biologicals Transfer Proposal between US and Indian Biotechnology
11. Vical Biotech and NIH jointly develops HIV vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... ... February 08, 2016 , ... Discover the Rocky Mountain region’s longest running ... 700 companies. Attendees also get to see the most incredible gardens and home ... Show , at the Colorado Convention Center - 700 14th St. Denver CO, is ...
(Date:2/8/2016)... KS (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com ... leader in Mole removal products. , Moles are derived from a cluster of melanin ... in all the wrong places and create a lifetime of embarrassment. Historically, mole ...
(Date:2/8/2016)... ... , ... The schedule is now online for the largest and ... is being held May 25-29 at the Loews Chicago O’Hare Hotel, continues to give ... of chronic illness in children. , Very recent articles have cited 1 child in ...
(Date:2/7/2016)... , ... February 07, 2016 , ... Women's Excellence staff, ... Wear Red Day. National Wear Red Day is the first Friday each February ... disease and stroke cause 1 in 3 deaths among women each year – more ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... 5000 PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT: ... world with an estimated 5000 perioperative nurses in attendance to study the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016  Avista Pharma Solutions ... Eric Setzer as Chief Financial Officer (CFO). Mr. Setzer ... years of experience in various roles within growing technology ... he served as the Executive Director of Finance at ... Raleigh, NC . Previously, Mr. Setzer ...
(Date:2/8/2016)... , Feb. 8, 2016 Vestagen Technical ... high performance apparel for healthcare and other demanding applications, ... Chief Executive Officer. He replaces Dale Pfost , ... Chairman. Mr. Bold is also joining Vestagen,s Board of ... new class of active barrier technologies that combines fluid ...
(Date:2/8/2016)... -- Astellas Pharma Inc. President and Chief Executive Officer Yoshihiko ... as president, Americas Operations, for Astellas US LLC, with ... South America , effective April 1, 2016.  Robinson previously ... in the United States -- a ... , who is retiring in June 2016.  --> ...
Breaking Medicine Technology: